Notably, CD14+ monocytes were also validated as the dominant cell population in PBMCs from SLE patients, suggesting that CD14+ monocytes in PBMCs may be a key cell population for diagnosing and understanding the common pathogenesis of SLE and PBC. This evidence concerns the gene CD14 and systemic lupus erythematosus.